Sample | Title | Value | Rank |
GSM146798 | Stage 1, PT#2, Normal (HG-U133B) | 3380.4 | 97 |
GSM146800 | Stage 1, PT#3, Normal (HG-U133B) | 4670.7 | 98 |
GSM146802 | Stage 1, PT#4, Normal (HG-U133B) | 3284.1 | 97 |
GSM146804 | Stage 1, PT#5,Normal (HG-U133B) | 2994.6 | 97 |
GSM146806 | Stage 1, PT#6, Normal (HG-U133B) | 2565.3 | 95 |
GSM146809 | Stage 2, PT#8, Normal (HG-U133B) | 2795.9 | 96 |
GSM146810 | Stage 2, PT#9, Normal (HG-U133B) | 2544.5 | 96 |
GSM146812 | Stage 2, PT#10, Normal (HG-U133B) | 2831.1 | 97 |
GSM146814 | Stage 2, PT#11, Normal (HG-U133B) | 3659 | 98 |
GSM146816 | Stage 2, PT#12, Normal (HG-U133B) | 3325.9 | 97 |
GSM146799 | Stage 1, PT#2, Tumor (HG-U133B) | 2017 | 93 |
GSM146801 | Stage 1, PT#3, Tumor (HG-U133B) | 2569.2 | 95 |
GSM146803 | Stage 1, PT#4,Tumor (HG-U133B) | 2454.5 | 95 |
GSM146805 | Stage 1, PT#5, Tumor (HG-U133B) | 2061.9 | 93 |
GSM146807 | Stage 1, PT#6,Tumor (HG-U133B) | 2280.6 | 95 |
GSM146808 | Stage 2, PT#8, Tumor (HG-U133B) | 1947.5 | 94 |
GSM146811 | Stage 2, PT#9, Tumor (HG-U133B) | 1959.8 | 93 |
GSM146813 | Stage 2, PT#10, Tumor (HG-U133B) | 2311.4 | 94 |
GSM146815 | Stage 2, PT#11, Tumor (HG-U133B) | 2338 | 95 |
GSM146817 | Stage 2, PT#12, Tumor (HG-U133B) | 2560.9 | 96 |